SynDRA canonical compound SYN0002422 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | RRM1 |
| Mechanism of action | Ribonucleotide reductase inhibitor |
| Indication | breast cancer | non-small cell lung cancer (NSCLC) | ovarian cancer | pancreatic cancer |
| Disease area | oncology |